These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 25937178

  • 1. Oxidative stress in paroxysmal nocturnal hemoglobinuria and other conditions of complement-mediated hemolysis.
    Fibach E, Dana M.
    Free Radic Biol Med; 2015 Nov; 88(Pt A):63-9. PubMed ID: 25937178
    [Abstract] [Full Text] [Related]

  • 2. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J, Zelig O, Fibach E.
    Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future.
    Risitano AM, Marotta S.
    Semin Immunol; 2016 Jun; 28(3):223-40. PubMed ID: 27346521
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders.
    Risitano AM.
    Immunobiology; 2012 Nov; 217(11):1080-7. PubMed ID: 22964233
    [Abstract] [Full Text] [Related]

  • 8. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X, Gavriilaki E, Thanassi JA, Yang G, Baines AC, Podos SD, Huang Y, Huang M, Brodsky RA.
    Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
    [Abstract] [Full Text] [Related]

  • 9. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.
    DeZern AE, Brodsky RA.
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):479-94. PubMed ID: 26043387
    [Abstract] [Full Text] [Related]

  • 10. Molecular pharmacology in complement-mediated hemolytic disorders.
    Bortolotti M, Barcellini W, Fattizzo B.
    Eur J Haematol; 2023 Sep; 111(3):326-336. PubMed ID: 37308291
    [Abstract] [Full Text] [Related]

  • 11. [Novel anti-complement therapeutics for hemolytic anemia].
    Nishimura JI.
    Rinsho Ketsueki; 2023 Sep; 64(6):466-473. PubMed ID: 37407469
    [Abstract] [Full Text] [Related]

  • 12. Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequence of subsequent discontinuation.
    Kurita N, Obara N, Fukuda K, Nishikii H, Sato S, Inagawa S, Kurokawa T, Owada Y, Ninomiya H, Chiba S.
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):658-62. PubMed ID: 23917586
    [Abstract] [Full Text] [Related]

  • 13. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
    Chen JY, Galwankar NS, Emch HN, Menon SS, Cortes C, Thurman JM, Merrill SA, Brodsky RA, Ferreira VP.
    Front Immunol; 2020 Sep; 11():1460. PubMed ID: 32793201
    [Abstract] [Full Text] [Related]

  • 14. Complement in hemolytic anemia.
    Brodsky RA.
    Hematology Am Soc Hematol Educ Program; 2015 Sep; 2015():385-91. PubMed ID: 26637747
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin.
    Ninomiya H, Kawashima Y, Nagasawa T.
    Br J Haematol; 2000 Jun; 109(4):875-81. PubMed ID: 10929045
    [Abstract] [Full Text] [Related]

  • 16. Paroxysmal nocturnal hemoglobinuria.
    Parker CJ.
    Curr Opin Hematol; 2012 May; 19(3):141-8. PubMed ID: 22395662
    [Abstract] [Full Text] [Related]

  • 17. Drugs that inhibit complement.
    Schrezenmeier H, Höchsmann B.
    Transfus Apher Sci; 2012 Feb; 46(1):87-92. PubMed ID: 22169380
    [Abstract] [Full Text] [Related]

  • 18. Complement in hemolytic anemia.
    Brodsky RA.
    Blood; 2015 Nov 26; 126(22):2459-65. PubMed ID: 26582375
    [Abstract] [Full Text] [Related]

  • 19. The role of complement inhibition in PNH.
    Hillmen P.
    Hematology Am Soc Hematol Educ Program; 2008 Nov 26; ():116-23. PubMed ID: 19074068
    [Abstract] [Full Text] [Related]

  • 20. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP.
    N Engl J Med; 2004 Feb 05; 350(6):552-9. PubMed ID: 14762182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.